Advertisement

Digestive Diseases and Sciences

, Volume 60, Issue 8, pp 2454–2462 | Cite as

The Trend of Inflammatory Bowel Diseases in Taiwan: A Population-Based Study

  • Chia-Jung Kuo
  • Kuang-Hui Yu
  • Lai-Chu See
  • Cheng-Tang ChiuEmail author
  • Ming-Yao Su
  • Chen-Ming Hsu
  • Chang-Fu Kuo
  • Meng-Jiun Chiou
  • Jia-Rou Liu
  • Hung-Wei Wang
Original Article

Abstract

Background and Aim

The purpose of this study was to estimate the sex- and age-specific incidence rates of inflammatory bowel diseases (IBD) in Taiwan. Site-specific cancer occurred in patients with IBD would be reported, too.

Methods

A retrospective study by analyzing the data from the National Health Insurance Research Database of Taiwan.

Results

Between 2000 and 2010, the overall incidence rate of Crohn’s disease (CD) and ulcerative colitis (UC) was 0.208 and 0.838 per 100,000 person-years. For male, the incidence rate of CD was 0.195 (95 % CI 0.113–0.276) per 100,000 persons in 2000 and increased to 0.318 (95 % CI 0.216–0.421) per 100,000 persons in 2010. For female, the incidence rate of CD was 0.092 (95 % CI 0.035–0.149) per 100,000 persons in 2000 and increased to 0.210 (95 % CI 0.128–0.293) per 100,000 persons in 2010. For male, the incidence rate of UC was 0.690 (95 % CI 0.537–0.843) per 100,000 persons in 2000 and increased to 1.351 (95 % CI, 1.140–1.562) per 100,000 persons in 2010. For female, the incidence rate of UC was 0.386 (95 % CI 0.269–0.503) per 100,000 persons in 2000 and increased to 0.858 (95 % CI 0.691–1.024) per 100,000 persons in 2010. Among the CD patients, 0.19 % had colorectal cancers (1/519). Among the UC patients, 0.24 % had colorectal cancers (5/2098).

Conclusions

This nationwide population-based longitudinal epidemiological study of IBD in Taiwan provides data for future global comparisons.

Keywords

Crohn’s disease Ulcerative colitis Sex- and age-specific incidence Cancer 

Notes

Acknowledgments

CJ Kuo, KH Yu, CT Chiu, MY Su, CM Hsu, CF Kuo, and HW Wang developed the study concept and design and provided the critical revision of the manuscript for important intellectual content. LC See, MJ Chiou, and JR Liu collected and interpreted the data. All authors approved the final version of the manuscript.

Conflict of interest

The authors report no conflicts of interest.

References

  1. 1.
    Abraham C, Cho Judy H. Inflammatory bowel disease. N Engl J Med. 2009;361:2066–2078.PubMedCentralPubMedCrossRefGoogle Scholar
  2. 2.
    Molodecky NA, Soon S, Rabi DM, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time based on systematic review. Gastroenterology. 2012;142:46–54.PubMedCrossRefGoogle Scholar
  3. 3.
    Economou M, Pappas G. New global map of Crohn’s disease: genetic, environmental, and socioeconomic correlations. Inflamm Bowel Dis. 2008;14:709–720.PubMedCrossRefGoogle Scholar
  4. 4.
    Thia KT, Loftus E, Sandborn WJ, Yang SK. An update on the epidemiology of inflammatory bowel disease in Asia. Am J Gastroenterol. 2008;103:3167–3182.PubMedCrossRefGoogle Scholar
  5. 5.
    Prideaux L, Kamm MA, De Cruz PP, Chan FK, Ng SC. Inflammatory bowel disease in Asia: a systematic review. J Gastroenterol Hepatol. 2012;27:1266–1280.PubMedCrossRefGoogle Scholar
  6. 6.
    Kuo CFSL, Yu KH, Chou IJ, et al. Epidemiology and mortality of systemic sclerosis: a nationwide population study in Taiwan. Scand J Rheumatol. 2011;40:373–378.PubMedCrossRefGoogle Scholar
  7. 7.
    Chiang C-J, Chen YC, Chen C-J, You S-L, Lai M-S, Taiwan cancer registry task force. Cancer Trends in Taiwan. Jpn J Clin Oncol. 2010;40:897–904.PubMedCrossRefGoogle Scholar
  8. 8.
    Ng SC, Tang W, Ching JY, et al. Incidence and phenotype of inflammatory bowel disease based on results from the Asia-pacific Crohn’s and colitis epidemiology study. Gastroenterology. 2013;145:158–165.PubMedCrossRefGoogle Scholar
  9. 9.
    Cosnes J, Gower-Rousseau C, Seksik P, et al. Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology. 2011;140:1785–1794.PubMedCrossRefGoogle Scholar
  10. 10.
    Gisbert JP, Chaparro M. Systematic review with meta-analysis: inflammatory bowel disease in the elderly. Alim Pharmacol Ther. 2014;39:459–477.CrossRefGoogle Scholar
  11. 11.
    Joannie R, Ruel CH, Charpentier C, Gower-Rousseau C, Colombel J-F. IBD in the elderly. Inflamm Bowel Dis Monit. 2013;14:1–11.Google Scholar
  12. 12.
    Ananthakrishnan ANBD. Treatment of ulcerative colitis in the elderly. Dig Dis. 2009;27:327–334.PubMedCrossRefGoogle Scholar
  13. 13.
    Katz S, Pardi DS. Inflammatory bowel disease of the elderly: frequently asked questions. Am J Gastroenterol. 2011;106:1889–1897.PubMedCrossRefGoogle Scholar
  14. 14.
    Herrinton LJLL, Levin TR, et al. Incidence and mortality of colorectal adenocarcinoma in persons with inflammatory bowel disease from 1998 to 2010. Gastroenterology. 2012;143:382–389.PubMedCrossRefGoogle Scholar
  15. 15.
    Pedersen NDD, Elkjaer M, Gamborg M, Munkholm P, Jess T. Risk of extra-intestinal cancer in inflammatory bowel disease: meta-analysis of population-based cohort studies. Am J Gastroenterol. 2010;105:1480–1487.PubMedCrossRefGoogle Scholar
  16. 16.
    Jess TRC, Peyrin-Biroulet L. Risk of colorectal cancer in patients with ulcerative colitis: a meta-analysis of population-based cohort studies. Clin Gastroenterol Hepatol. 2012;10:639–645.PubMedCrossRefGoogle Scholar
  17. 17.
    Ooi CJ, Fock KM, Makharia GK. The Asia-Pacific consensus on ulcerative colitis. J Gastroenterol Hepatol. 2010;25:453–468.PubMedCrossRefGoogle Scholar
  18. 18.
    Katsanos KH, Pedersen N, Shuhaibar M, et al. Cancer in inflammatory bowel disease 15 years aft er diagnosis in a population-based European Collaborative follow-up study. J Crohns Colitis. 2011;5:430–442.PubMedCrossRefGoogle Scholar
  19. 19.
    Kim BJYS, Kim JS, Jeen YT, et al. Trends of ulcerative colitis-associated colorectal cancer in Korea: a KASID study. J Gastroenterol Hepatol. 2009;24:667–671.PubMedCrossRefGoogle Scholar
  20. 20.
    Wei S-C, Shieh MJ, Chang MC, Chang YT, Wang C-Y, Wong J-M. Long-term follow-up of ulcerative colitis in Taiwan. J Chin Med Assoc. 2012;75:151–155.PubMedCrossRefGoogle Scholar
  21. 21.
    Rutter MD, Saunder BP, Wilkinson KH, et al. Thirty year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis. Gastroenterology. 2006;130:1030–1038.PubMedCrossRefGoogle Scholar
  22. 22.
    Jess T, Horvath-Puho E, Fallingborg J, Rasmussen HH, Jacobsen BA. Cancer risk in inflammatory bowel disease according to patient phenotype and treatment: a danish population-based cohort study. Am J Gastroenterol. 2013;108:1869–1876.PubMedCrossRefGoogle Scholar
  23. 23.
    Long MD, Martin CF, Pipkin CA, Herfarth HH, Sandler RS, Kappelman MD. Risk of melanoma and nonmelanoma skin cancer among patients with inflammatory bowel disease. Gastroenterology. 2012;143:390–399.PubMedCentralPubMedCrossRefGoogle Scholar
  24. 24.
    Jess T, Simensen J, Jørgensen KT, Pedersen BV, Nielsen NM, Frisch M. Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30 years. Gastroenterology. 2012;143:375–381.PubMedCrossRefGoogle Scholar
  25. 25.
    Kappelman MD, Farkas D, Long MD, et al. Risk of cancer in patients with inflammatory bowel diseases: a nationwide population-based cohort study with 30 years of follow-up evaluation. Clin Gastroenterol Hepatol. 2014;12:265–273.PubMedCentralPubMedCrossRefGoogle Scholar
  26. 26.
    Zheng JJZX, Huangfu Z, Shi XH, Guo ZR. Prevalence and incidence rates of Crohn’s disease in mainland China: a meta-analysis of 55 years of research. J Dig Dis. 2010;11:161–166.PubMedCrossRefGoogle Scholar
  27. 27.
    Asakura KNY, Inoue N, Hibi T, Watanabe M, Takebayashi T. Prevalence of ulcerative colitis and Crohn’s disease in Japan. J Gastroenterol. 2009;44:659–665.PubMedCrossRefGoogle Scholar
  28. 28.
    Yao TMT, Hiwatashi N. Crohn’s disease in Japan: diagnostic criteria and epidemiology. Dis Colon Rectum. 2000;43:S85–S93.PubMedCrossRefGoogle Scholar
  29. 29.
    Yang SKYS, Kim JH, Park JY, et al. Epidemiology of inflammatory bowel disease in the Songpa-Kangdong district, Seoul, Korea, 1986–2005: a KASID study. Inflamm Bowel Dis. 2008;14:542–549.PubMedCrossRefGoogle Scholar
  30. 30.
    Sood AMV, Sood N, Bhatia AS, Avasthi G. Incidence and prevalence of ulcerative colitis in Punjab. North India Gut. 2003;52:1587–1590.CrossRefGoogle Scholar
  31. 31.
    Lee YMFK, See SJ, Ng TM, Khor C, Teo EK. Racial differences in the prevalence of ulcerative colitis and Crohn’s disease in Singapore. J Gastroenterol Hepatol. 2000;15:622–625.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2015

Authors and Affiliations

  • Chia-Jung Kuo
    • 1
    • 2
  • Kuang-Hui Yu
    • 2
    • 3
  • Lai-Chu See
    • 2
    • 4
    • 5
  • Cheng-Tang Chiu
    • 1
    • 2
    Email author
  • Ming-Yao Su
    • 1
    • 2
  • Chen-Ming Hsu
    • 1
    • 2
  • Chang-Fu Kuo
    • 2
    • 3
  • Meng-Jiun Chiou
    • 2
    • 4
    • 5
  • Jia-Rou Liu
    • 2
    • 4
    • 5
  • Hung-Wei Wang
    • 1
  1. 1.Department of Gastroenterology and Hepatology, College of Medicine, Chang Gung Memorial HospitalChang Gung UniversityTaoyuanTaiwan, ROC
  2. 2.College of MedicineChang Gung UniversityTaoyuanTaiwan, ROC
  3. 3.Division of Rheumatology, Allergy, and ImmunologyChang Gung Memorial HospitalTaoyuanTaiwan, ROC
  4. 4.Department of Public Health, Biostatistics Consulting CenterChang Gung UniversityTaoyuanTaiwan, ROC
  5. 5.Biostatistics Core Laboratory, Molecular Medical Research CenterChang Gung UniversityTaoyuanTaiwan, ROC

Personalised recommendations